These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 18385443)

  • 1. Performance of HerpeSelect and Kalon assays in detection of antibodies to herpes simplex virus type 2.
    LeGoff J; Mayaud P; Gresenguet G; Weiss HA; Nzambi K; Frost E; Pepin J; Belec L;
    J Clin Microbiol; 2008 Jun; 46(6):1914-8. PubMed ID: 18385443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herpes simplex virus type 2 antibody detection performance in Kisumu, Kenya, using the Herpeselect ELISA, Kalon ELISA, Western blot and inhibition testing.
    Smith JS; Bailey RC; Westreich DJ; Maclean I; Agot K; Ndinya-Achola JO; Hogrefe W; Morrow RA; Moses S
    Sex Transm Infect; 2009 Apr; 85(2):92-6. PubMed ID: 18955387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of focus HerpesSelect and Kalon HSV-2 gG2 ELISA serological assays to detect herpes simplex virus type 2 antibodies in a South African population.
    Delany-Moretlwe S; Jentsch U; Weiss H; Moyes J; Ashley-Morrow R; Stevens W; Mayaud P
    Sex Transm Infect; 2010 Feb; 86(1):46-50. PubMed ID: 19837726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of the HerpeSelect (Focus) and Kalon enzyme-linked immunosorbent assays for detection of antibodies against herpes simplex virus type 2 by use of monoclonal antibody-blocking enzyme immunoassay and clinicovirological reference standards in Brazil.
    Nascimento MC; Ferreira S; Sabino E; Hamilton I; Parry J; Pannuti CS; Mayaud P
    J Clin Microbiol; 2007 Jul; 45(7):2309-11. PubMed ID: 17507516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the HerpeSelect Express rapid test in the detection of herpes simplex virus type 2 antibodies in patients with genital ulcer disease.
    Al-Shobaili H; Hassanein KM; Mostafa MS; Al Duways AS
    J Clin Lab Anal; 2015 Jan; 29(1):43-6. PubMed ID: 24687953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of acyclovir on genital and plasma HIV-1 RNA, genital herpes simplex virus type 2 DNA, and ulcer healing among HIV-1-infected African women with herpes ulcers: a randomized placebo-controlled trial.
    Mayaud P; Legoff J; Weiss HA; Grésenguet G; Nzambi K; Bouhlal H; Frost E; Pépin J; Malkin JE; Hayes RJ; Mabey DC; Bélec L;
    J Infect Dis; 2009 Jul; 200(2):216-26. PubMed ID: 19530940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of the focus and Kalon enzyme-linked immunosorbent assays for antibodies to herpes simplex virus type 2 glycoprotein G in culture-documented cases of genital herpes.
    Morrow RA; Friedrich D; Krantz E
    J Clin Microbiol; 2003 Nov; 41(11):5212-4. PubMed ID: 14605166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. False-negative type-specific glycoprotein G antibody responses in STI clinic patients with recurrent HSV-1 or HSV-2 DNA positive genital herpes, The Netherlands.
    van Rooijen MS; Roest W; Hansen G; Kwa D; de Vries HJ
    Sex Transm Infect; 2016 Jun; 92(4):257-60. PubMed ID: 26755775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time course of seroconversion by HerpeSelect ELISA after acquisition of genital herpes simplex virus type 1 (HSV-1) or HSV-2.
    Ashley-Morrow R; Krantz E; Wald A
    Sex Transm Dis; 2003 Apr; 30(4):310-4. PubMed ID: 12671550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervicovaginal HIV-1 and herpes simplex virus type 2 shedding during genital ulcer disease episodes.
    LeGoff J; Weiss HA; Gresenguet G; Nzambi K; Frost E; Hayes RJ; Mabey DC; Malkin JE; Mayaud P; Belec L
    AIDS; 2007 Jul; 21(12):1569-78. PubMed ID: 17630552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved performance of enzyme-linked immunosorbent assays and the effect of human immunodeficiency virus coinfection on the serologic detection of herpes simplex virus type 2 in Rakai, Uganda.
    Gamiel JL; Tobian AA; Laeyendecker OB; Reynolds SJ; Morrow RA; Serwadda D; Gray RH; Quinn TC
    Clin Vaccine Immunol; 2008 May; 15(5):888-90. PubMed ID: 18321879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of focus ELISA tests for herpes simplex virus type 1 (HSV-1) and HSV-2 antibodies among women in ten diverse geographical locations.
    Ashley-Morrow R; Nollkamper J; Robinson NJ; Bishop N; Smith J
    Clin Microbiol Infect; 2004 Jun; 10(6):530-6. PubMed ID: 15191381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of four diagnostic assays for detecting herpes simplex virus type 2 antibodies in the Middle East and North Africa.
    Nasrallah GK; Dargham SR; Sahara AS; Elsidiq MS; Abu-Raddad LJ
    J Clin Virol; 2019 Feb; 111():33-38. PubMed ID: 30639845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of commercial herpes simplex virus type-2 antibody tests using serum samples from Sub-Saharan Africa: a systematic review and meta-analysis.
    Biraro S; Mayaud P; Morrow RA; Grosskurth H; Weiss HA
    Sex Transm Dis; 2011 Feb; 38(2):140-7. PubMed ID: 20706175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity and specificity of herpes simplex virus-2 serological assays among HIV-infected and uninfected urban Ugandans.
    Lingappa J; Nakku-Joloba E; Magaret A; Friedrich D; Dragavon J; Kambugu F; Joloba M; Whalen C; Coombs R; Celum C; Morrow RA
    Int J STD AIDS; 2010 Sep; 21(9):611-6. PubMed ID: 21097732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of "biokit HSV-2 Rapid Assay" to improve the positive predictive value of Focus HerpeSelect HSV-2 ELISA.
    Morrow RA; Friedrich D; Meier A; Corey L
    BMC Infect Dis; 2005 Oct; 5():84. PubMed ID: 16225691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of HSV-2 type specific serological tests in men in Kenya.
    Ng'ayo MO; Friedrich D; Holmes KK; Bukusi E; Morrow RA
    J Virol Methods; 2010 Feb; 163(2):276-81. PubMed ID: 19854222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment.
    Wald A; Corey L; Cone R; Hobson A; Davis G; Zeh J
    J Clin Invest; 1997 Mar; 99(5):1092-7. PubMed ID: 9062368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-collected genital swabs compared with cervicovaginal lavage for measuring HIV-1 and HSV-2 and the effect of acyclovir on viral shedding.
    McNicholl JM; Leelawiwat W; Whitehead S; Hanson DL; Evans-Strickfaden T; Cheng CY; Chonwattana W; Mueanpai F; Kittinunvorakoon C; Markowitz L; Dunne EF
    Int J STD AIDS; 2017 Mar; 28(4):372-379. PubMed ID: 27179350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precision of the Kalon Herpes Simplex Virus Type 2 IgG ELISA: an international inter-laboratory assessment.
    Patel EU; Manucci J; Kahle EM; Lingappa JR; Morrow RA; Piwowar-Manning E; James A; Maluzi KF; Cheeba MM; Gray G; Kosloff B; Delany-Moretlwe S; Inambao M; Vwalika B; Quinn TC; Laeyendecker O
    BMC Infect Dis; 2015 Sep; 15():398. PubMed ID: 26423888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.